Galectin Therapeutics Inc. (GALT)

NASDAQ: GALT · Real-Time Price · USD

Compare

4.380

-1.780 (-28.90%)

At close: Dec 19, 2025, 4:00 PM EST

4.350

-0.030 (-0.68%)

After-hours: Dec 19, 2025, 7:59 PM EST

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $282.39 million as of December 19, 2025. Its market cap has increased by 73.03% in one year.

Market Cap

282.39M

Enterprise Value

393.05M

1-Year Change

73.03%

Ranking

#3601

Market Cap Chart

Since September 10, 2003, Galectin Therapeutics's market cap has increased from $106.80M to $282.39M, an increase of 164.41%. That is a compound annual growth rate of 4.46%.

Market Cap History

Date	Market Cap	% Change
Dec 18, 2025	397.20M	390.37%
Dec 31, 2024	81.00M	-21.13%
Dec 29, 2023	102.70M	52.83%
Dec 30, 2022	67.20M	-45.28%
Dec 31, 2021	122.80M	-3.99%
Dec 31, 2020	127.90M	-21.39%
Dec 31, 2019	162.70M	15.31%
Dec 31, 2018	141.10M	18.57%
Dec 29, 2017	119.00M	313.19%
Dec 30, 2016	28.80M	-26.53%
Dec 31, 2015	39.20M	-48.96%
Dec 31, 2014	76.80M	-48.11%
Dec 31, 2013	148.00M	352.60%
Dec 31, 2012	32.70M	-55.81%
Dec 30, 2011	74.00M	32.14%
Dec 31, 2010	56.00M	288.89%
Dec 31, 2009	14.40M	234.88%
Dec 31, 2008	4.30M	-84.81%
Dec 31, 2007	28.30M	111.19%
Dec 29, 2006	13.40M	-83.91%
Dec 30, 2005	83.30M	21.96%
Dec 31, 2004	68.30M	-23.94%
Dec 31, 2003	89.80M	-15.92%
Sep 10, 2003	106.80M	-

View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	943.99B
Johnson & Johnson	504.27B
AbbVie	395.31B
UnitedHealth Group	302.73B
AstraZeneca	281.22B
Novartis AG	259.57B
Merck & Co.	243.91B
Abbott Laboratories	220.59B

Market Cap Rankings